Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome. (Q50938799)
Jump to navigation
Jump to search
scientific article published on 29 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome. |
scientific article published on 29 July 2013 |
Statements
Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome. (English)
1 reference
Karin Boslooper
1 reference
Robby Kibbelaar
1 reference
Huib Storm
1 reference
Nic J G M Veeger
1 reference
Sjoerd Hovenga
1 reference
Gerhard Woolthuis
1 reference
Bas van Rees
1 reference
Elly de Graaf
1 reference
Eric van Roon
1 reference
Peter Joosten
1 reference
Mels Hoogendoorn
1 reference
29 July 2013
1 reference
55
1 reference
3
1 reference
526-532
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference